Lucentis
Lucentis is a medicine authorised by Swissmedic under authorisation number 63277. The authorisation holder is Novartis Pharma Schweiz AG. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 29 January 2014 and the authorisation is valid without a time limit. ATC code S01LA04 places the medicine in the group Ophthalmologicals.
| Authorisation number | 63277 |
|---|---|
| Name | Lucentis |
| Full name | Lucentis, Injektionslösung zur intravitrealen Anwendung in Fertigspritze |
| Authorisation holder | Novartis Pharma Schweiz AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | B · Prescription only |
| ATC code | S01LA04 |
| First authorisation | 29 January 2014 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Lucentis, Injektionslösung zur intravitrealen Anwendung in Fertigspritze | B | 29 January 2014 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Fertigspritze(n) | S01LA04 | 11.99.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Lucentis authorised in Switzerland?
Yes. Lucentis is authorised by Swissmedic under authorisation number 63277, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Lucentis have?
Lucentis is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Lucentis?
The authorisation holder is Novartis Pharma Schweiz AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.